share_log

Molina Healthcare's (NYSE:MOH) Five-year Earnings Growth Trails the 22% YoY Shareholder Returns

Molina Healthcare's (NYSE:MOH) Five-year Earnings Growth Trails the 22% YoY Shareholder Returns

molina healthcare(紐交所:MOH)的五年盈利增長落後於22%的年度股東回報
Simply Wall St ·  10/25 20:32

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But on a lighter note, a good company can see its share price rise well over 100%. One great example is Molina Healthcare, Inc. (NYSE:MOH) which saw its share price drive 175% higher over five years. And in the last week the share price has popped 12%. The company reported its financial results recently; you can catch up on the latest numbers by reading our company report.

當您購買一家公司的股票時,值得記住它可能會失敗,您可能會損失資金。但是換個角度看,一家好公司的股價可能會上漲超過100%。一個很好的例子是Molina Healthcare公司(紐交所:MOH),在過去五年裏,其股價上漲了175%。上週股價上漲了12%。該公司最近公佈了財務業績;您可以通過閱讀我們的公司報告了解最新數據。

The past week has proven to be lucrative for Molina Healthcare investors, so let's see if fundamentals drove the company's five-year performance.

過去一週對Molina Healthcare的投資者來說是賺錢的,讓我們看看基本面是否推動了公司的五年表現。

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

雖然有效市場假說仍然被一些人教授,但被證明市場是過度反應的動態系統,投資者並不總是理性的。檢查市場情緒如何隨時間變化的一種方法是看一個公司的股價與其每股收益(EPS)之間的交互作用。

During five years of share price growth, Molina Healthcare achieved compound earnings per share (EPS) growth of 9.5% per year. This EPS growth is lower than the 22% average annual increase in the share price. This suggests that market participants hold the company in higher regard, these days. And that's hardly shocking given the track record of growth.

在五年的股價增長過程中,Molina Healthcare實現了每年9.5%的複合每股收益(EPS)增長。這種EPS增長低於股價每年增長22%的平均水平。這表明市場參與者如今更看好這家公司。考慮到增長記錄,這並不令人意外。

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

下面可以看到每股收益隨時間的變化情況(通過點擊圖像來查看確切數值)。

big
NYSE:MOH Earnings Per Share Growth October 25th 2024
紐交所:MOH 每股收益增長 2024年10月25日

We know that Molina Healthcare has improved its bottom line lately, but is it going to grow revenue? Check if analysts think Molina Healthcare will grow revenue in the future.

我們知道Molina Healthcare 最近改善了其底線,但它將增長營業收入嗎?請查看分析師是否認爲 Molina Healthcare 將來會增長營業收入。

A Different Perspective

不同的觀點

Investors in Molina Healthcare had a tough year, with a total loss of 2.4%, against a market gain of about 42%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. On the bright side, long term shareholders have made money, with a gain of 22% per year over half a decade. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with Molina Healthcare , and understanding them should be part of your investment process.

Molina Healthcare 的投資者經歷了艱難的一年,總虧損達到2.4%,相比市場約42%的收益。然而,要記住,即使最好的股票有時也會在十二個月的時間裏表現不佳。從好的一面來看,長期股東每年可獲得22%的收益,超過半個十年。如果基本數據繼續顯示長期可持續增長,當前的拋售可能是值得考慮的機會。 雖然考慮市場條件對股價的影響是非常值得的,但有其他更重要的因素。例如,始終存在的投資風險。我們已經確定了1個與Molina Healthcare 相關的警示信號,理解它們應該是你投資過程的一部分。

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: many of them are unnoticed AND have attractive valuation).

如果您喜歡與管理層一起購買股票,那麼您可能會喜歡這個公司的免費列表。 (提示:其中許多公司不爲人注意且具有吸引力的估值。)

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文所引述的市場回報反映了目前在美國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論